Galenea's Grant

Galenea raised a round of funding on November 10, 2005. Investors include National Institute of Allergy and Infectious Diseases.

Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…

Articles about Galenea's Grant: